Clinical trials showed approximately 15% average body weight reduction with semaglutide, compared to 20-25% with tirzepatide
1012 Artificial intelligence meets clinical trial design: A test case in predicting patient achievement of minimal significant difference using conditional generative adversarial networks Siddharth Kakked 1 1 OPEN Health, Falmouth, Maine, USA Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :1012 Aims This study investigates whether a conditional Generative Adversarial Network (cGAN) can reliably predict the probability of successfully achieving a clinical trial endpoint
A smaller share, 2.7 percent, discontinued in the placebo group
Until recently, the skin was observed on the basis of its layers: epidermis, dermis and hypodermis (subcutis)
Possible effect modification by age, sex, diabetes status, glycemic control, obesity, CVD, and other comorbidities, as well as compounds, administration methods, and dosages of GLP-1 RAs should be evaluated